Xilio Therapeutics, Inc. (XLO) Appoints Dr. Yariv J. Houvras as Chief Medical Officer

Xilio Therapeutics appointed Yariv J. Houvras, M.D., Ph.D. as chief medical officer, bringing 20+ years in clinical development and immuno-oncology.Material DetailsContext by AI AnalystThis is a management upgrade amid ongoing clinical development of masked immuno-oncology assets, including XTX501…